2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Multiple Organ Failure in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, GE | 1 |
| Sokol, KK | 1 |
| Moe, DM | 1 |
| Simmons, JD | 1 |
| Muscat, D | 1 |
| Pastukh, V | 1 |
| Capley, G | 1 |
| Gorodnya, O | 1 |
| Ruchko, M | 1 |
| Roth, MB | 1 |
| Gillespie, M | 1 |
| Martin, MJ | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Multiple Organ Failure
| Article | Year |
|---|---|
Impact of a novel phosphoinositol-3 kinase inhibitor in preventing mitochondrial DNA damage and damage-associated molecular pattern accumulation: Results from the Biochronicity Project.
Topics: Animals; Chromones; Disease Models, Animal; DNA Damage; DNA, Mitochondrial; Energy Metabolism; Enzym | 2017 |